Views & Analysis

Views & Analysis
What should industry consider next time

VPAS 2024: What should industry consider next time?

The UK pharmaceutical industry is just getting to grips with working under two new approaches to regulating branded medicines spend; the 2019 Voluntary Scheme for Branded Medicines Pricing

Views & Analysis
The new era of healthcare communications

The new era of healthcare communications

We speak to McCann Health to find out how the agency is adapting to a world where healthcare communications are becoming broader and more innovative than ever before.

Views & Analysis
Engaging HCPs through digital media

Engaging HCPs through digital media

The ubiquity of digital technology allows pharma reps to communicate with healthcare professionals (HCPs) through their preferred channels, making a positive difference to engagement, relat